DECESARISPROUT CANCER FOUNDATION INC (EIN 261885956) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2007

Legal Domicile

Principal Officer

JOANN DECESARIS

Tax Period

2023-01-01 to 2023-12-31

DECESARISPROUT CANCER FOUNDATION INC, founded in 2007, is a micro nonprofit in the Medical Research sector that reported $84K in total revenue in fiscal year 2023. Revenue surged 48% from the prior year, signaling strong growth momentum. The organization ran a surplus of $81K, a strong 97% operating margin.

Mission

TO MAKE A PROFOUND AFFECT IN RESEARCH ON LUNG AND OVARIAN CANCER, AND TO MAKE A DIFFERENCE IN THIS DREADFUL DISEASE BY NOT ONLY BETTER TREATMENT OPTIONS, BUT FINDING A CURE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $131,074

Program Service Revenue $0

Investment Income $21,439

Other Revenue $-68,700

TOTAL REVENUE $83,813

Expense Breakdown

Grants Paid $1,000

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $1,000

Other Expenses $1,384

TOTAL EXPENSES $2,384

Year-over-Year Comparison

	2023	2022	Change
Revenue	$83,813	$56,465	+0.5%
Expenses	$2,384	$28,215	-0.9%
Net Income	$81,429	$28,250	+1.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

100

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JOANN M DECESARIS	PRESIDENT/TREASURER	0.0	Officer	$0	$0	$0
ELIZABETH PROUT LENNON	VICE PRESIDENT/SECRETARY	0.0	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$83,813	$2,384	$810,735	$81,429
2022	$56,465	$28,215	$729,306	$28,250
2021	$37,398	$32,949	$701,056	$4,449
2020	$36,542	$34,830	$696,607	$1,712
2019	$75,874	$54,241	$694,895	$21,633
2018	$74,702	$40,181	$673,263	$34,521

DECESARISPROUT CANCER FOUNDATION INC